Stay up to date on the latest oncology and nursing conferences.
Ribociclib Plus Letrozole Safety Profile Has Some Surprising Adverse Effects
May 17th 2018Ribociclib (Kisqali), a targeted CDK4/6 inhibitor, is gaining traction in the treatment of hormone receptor–positive, human epidermal growth factor receptor (HER) 2–negative advanced breast cancer, and nurses and patients need to be educated about its possible adverse effects (AEs).
PFS Improves with Ribociclib Use in Younger Women with HR+/HER2- Breast Cancer
December 12th 2017Results of a new study show that adding ribociclib (Kisqali) to standard endocrine therapy with temporary ovarian suppression significantly improved progression-free survival (PFS) when used as a first-line treatment for
When Young Women Have Breast Cancer – Understanding Their Needs
May 15th 2017Examining the experience of 3 women, aged 24 to 28, with stage III breast cancer, oncology nurses from the University of Texas at Austin School of Nursing aimed to gain more insight into the experience of younger woman with breast cancer.
Telemedicine Can Be an Effective Way to Help People Quit Smoking
May 15th 2017Nurses at UT Southwestern's Simmons Comprehensive Cancer Center in Dallas found a telemedicine smoking cessation program to be successful for male smokers in a local homeless shelter, as reported at the 42nd Annual ONS Congress.
Location, Location, Location: Red Box Eases Anxiety in the Infusion Room
May 7th 2017As presented at the 2017 ONS Annual Congress, nurses at Cancer Treatment Centers of America at Eastern Medical Center developed an emergency supply box for the occurrence of hypersensitivity reactions during cancer therapy infusions.
A New Core Measure of Sepsis Aims to Improve Screening Criteria and Save Lives
May 5th 2017Nurses at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins implemented an intervention to reduce the missed cases of sepsis in oncology patients, as presented at the 2017 Oncology Nursing Society's Annual Congress